Clinical Implications of Multiplex Imaging
In 2021, over 1,000,000 new cases of cancer and over 600,000 cancer deaths are projected to occur in the [...]
Leica Biosystems and Visikol to Host Multiplex Webinar
Visikol CEO Dr. Michael Johnson will be hosting a webinar with Leica Biosystems discussing multiplex imaging and the Leica [...]
Visikol Launches BitSlide, Cloud-Based Digital Pathology Slide Visualization Platform
Visikol has been a leader in advanced bioimaging through its portfolio of cutting-edge technologies and innovative drug discovery, bioimaging, [...]
Using Immunohistochemistry and Multiplex Slide Labeling for Tumor Research
Accurate prediction and prognosis as well as patient stratification for precision therapy are the most important and difficult issues [...]
High Content Screening for Immune Modulators
Cancer immunotherapies that target T cells via the blockage of immune checkpoints are a promising approach for cancer treatment. [...]
Visikol uses Multiplex Imaging Tools in Partnership with Hackensack Meridian Health
Tuberculosis (TB) is still one of the top ten leading causes of death globally. Although TB is both preventable [...]
Visikol Adds the Leica Aperio VERSA 8 Fluorescent Slide Scanner
Visikol added the Leica Biosystems’ Aperio VERSA 8 slide scanner to its services as the company expands its suite [...]
Visikol Launches Multiplex Slide Imaging and Analysis Services
The Visikol research team has developed a novel tissue multiplexing approach which leverages a proprietary antibody [...]
Visikol Partners with Fluidigm to offer its Clients Imaging Mass Cytometry Services
Visikol originally began a little over four years ago focused entirely on providing researchers with reagents to image tissues [...]
Visikol Launches Imaging Mass Cytometry Services
Hampton, NJ --- As a leader in advanced tissue imaging and digital pathology services, Visikol is excited to announce [...]